Tanke Biosciences Corp (TNBI) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
ROOM 2801, EAST TOWER OF HUI HAO BLDG PEARL RIVER NEW CITY GUANGZHOU, 510627 |
| State of Incorp. | NV |
| Fiscal Year End | December 31 |
| Industry (SIC) | 204 - Grain Mill Products (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2013 MRQ | 12/31/2012 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 6,169 | |||
| Cash and cash equivalent | 6,169 | |||
| Receivables | 4,880 | |||
| Inventory, net of allowances, customer advances and progress billings | ✕ | 1,415 | ||
| Inventory | 1,415 | |||
| Deferred costs | 116 | |||
| Prepaid expense and other current assets | ✕ | 9,162 | ||
| Other undisclosed current assets | 627 | |||
| Total current assets: | 22,368 | |||
| Noncurrent Assets | ||||
| Property, plant and equipment | 4,813 | |||
| Intangible assets, net (including goodwill) | ✕ | 1,238 | ||
| Intangible assets, net (excluding goodwill) | 1,238 | |||
| Prepaid expense and other noncurrent assets | ✕ | 135 | ||
| Other undisclosed noncurrent assets | 295 | |||
| Total noncurrent assets: | 6,481 | |||
| TOTAL ASSETS: | 28,849 | |||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 3,516 | |||
| Taxes payable | 1,927 | |||
| Accounts payable | 647 | |||
| Accounts payable and other accrued liabilities | 943 | |||
| Debt | 1,268 | |||
| Other undisclosed current liabilities | 7,311 | |||
| Total current liabilities: | 12,096 | |||
| Noncurrent Liabilities | ||||
| Long-term debt and lease obligation | 793 | |||
| Long-term debt, excluding current maturities | 793 | |||
| Other undisclosed noncurrent liabilities | 38 | |||
| Total noncurrent liabilities: | 831 | |||
| Total liabilities: | 12,926 | |||
| Equity | ||||
| Equity, attributable to parent, including: | 15,752 | |||
| Common stock | 13 | |||
| Additional paid in capital | 12,220 | |||
| Accumulated other comprehensive income | 659 | |||
| Retained earnings | 2,486 | |||
| Other undisclosed equity, attributable to parent | 373 | |||
| Equity, attributable to noncontrolling interest | 171 | |||
| Total equity: | 15,923 | |||
| TOTAL LIABILITIES AND EQUITY: | 28,849 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2013 TTM | 12/31/2012 | ||
|---|---|---|---|
| Revenues (Revenue, Net) | 28,562 | ||
| Cost of revenue (Cost of Product and Service Sold) | (18,618) | ||
| Other undisclosed gross profit | 0 | ||
| Gross profit: | 9,944 | ||
| Operating expenses | (5,801) | ||
| Other undisclosed operating income | 388 | ||
| Operating income: | 4,532 | ||
| Nonoperating income (Investment Income, Nonoperating) | 296 | ||
| Interest and debt expense | (1,446) | ||
| Income from continuing operations before equity method investments, income taxes: | 3,381 | ||
| Other undisclosed loss from continuing operations before income taxes | (2,779) | ||
| Income from continuing operations before income taxes: | 603 | ||
| Income tax expense | (832) | ||
| Loss from continuing operations: | (229) | ||
| Loss before gain (loss) on sale of properties: | (229) | ||
| Net loss: | (229) | ||
| Net income attributable to noncontrolling interest | 19 | ||
| Net loss available to common stockholders, diluted: | (210) | ||
Comprehensive Income ($ in thousands)
| 9/30/2013 TTM | 12/31/2012 | ||
|---|---|---|---|
| Net loss: | (229) | ||
| Other undisclosed comprehensive income | 108 | ||
| Comprehensive loss: | (121) | ||
| Comprehensive loss, net of tax, attributable to noncontrolling interest | (19) | ||
| Other undisclosed comprehensive income, net of tax, attributable to parent | 37 | ||
| Comprehensive loss, net of tax, attributable to parent: | (103) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.